Blind Man, ‘Born to Run,’ Completes Solo 5K With Trial App to Guide Him | Technology News

NEW YORK (Reuters) – A blind man completed a 5-kilometer (3.1-mile) run in New York’s Central Park without a guide dog or human help this week. His navigation aid? Artificial intelligence through headphones plugged into a smartphone.

“The safest thing for a blind man is to sit still. I ain’t sitting still,” said Thomas Panek, 50, who lost his vision in his early 20s due to a genetic condition and runs Guiding Eyes for the Blind, a guide dog school.

The marathon enthusiast got tired of having to follow slower runners as a guide. So he decided a year ago to find a way to run solo.

He turned to Google to find a way for a phone to “tell me where to go,” said Panek, who believes “humans are born to run.”

He worked with the Alphabet Inc unit to create a research program. A smartphone camera picks up

Read More

Blind man, ‘born to run,’ completes solo 5K with trial app to guide him

NEW YORK (Reuters) – A blind man completed a 5-kilometer (3.1-mile) run in New York’s Central Park without a guide dog or human help this week. His navigation aid? Artificial intelligence through headphones plugged into a smartphone.

“The safest thing for a blind man is to sit still. I ain’t sitting still,” said Thomas Panek, 50, who lost his vision in his early 20s due to a genetic condition and runs Guiding Eyes for the Blind, a guide dog school.

The marathon enthusiast got tired of having to follow slower runners as a guide. So he decided a year ago to find a way to run solo.

He turned to Google to find a way for a phone to “tell me where to go,” said Panek, who believes “humans are born to run.”

He worked with the Alphabet Inc unit to create a research program. A smartphone camera picks up

Read More

Internet Heaps Praise on Dolly Parton After She Donated $1m to COVID-19 Vaccine Trial

Dolly Parton has once again demonstrated why she is so beloved around the world after donating $1 million to a COVID-19 vaccine trial that has been highly successful.

U.S. biotechnology firm Moderna announced on Monday that its vaccine was over 94 percent effective in protecting against coronavirus. It has now emerged that the country singer and philanthropist donated the sum towards the research for this trial.

The news follows the announcement of a separate vaccine from pharmaceutical firm Pfizer last week.

Parton’s donation came through her support of the Vanderbilt University Medical Center in Nashville, Tennessee. The New England Journal of Medicine has reported that she donated her own money to aid the research earlier this year. Footnotes in the journal show that funding came from the “Dolly Parton COVID-19 Research Fund.”

Dolly Parton
Singer-songwriter Dolly Parton attends the 51st Academy of Country Music Awards at MGM Grand Garden Arena on April
Read More

Rigel Finalizes the Study Design of its Ongoing Phase 3 Clinical Trial of Fostamatinib in Warm Autoimmune Hemolytic Anemia

FDA agrees to the proposed primary efficacy endpoint and additional secondary endpoints

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on the final design of its FORWARD study, a pivotal Phase 3 clinical trial of fostamatinib disodium hexahydrate (fostamatinib) in warm autoimmune hemolytic anemia (AIHA). The FDA agreed to Rigel’s proposed durable response measure for the primary efficacy endpoint as well as the inclusion of additional secondary endpoints.  

The Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study of approximately 90 patients with primary or secondary warm AIHA who have failed at least one prior treatment. The primary efficacy endpoint for the trial is a durable response defined as a hemoglobin level ≥ 10 g/dl with an increase from baseline of ≥ 2 g/dl on three consecutive

Read More

Alek Minassian’s father testifies in van attack trial his son was about to start a good computer job

Article content continued

He paused in his testimony as he became emotional.

He said he watched video of his son pulling his hand out of his pocket and pointing it at police, pretending he had a gun.

“I was in a state of shock,” he said. “How is this even possible?”

He testified there was no hint of his son being capable of it.

“I’ve seen no history of violence. He is, if anything, he’s always been characterized as a gentle person.”

Minassian’s father said his son had problems from a young age because of odd behaviours. He was in a special education program throughout his schooling. In some subjects, such as math, he was ahead of his peers but in other he was far behind.

Social interaction, he said, “was one of the greatest challenges he had.” He did not recognize facial expressions that reveal other’s emotional state, such

Read More

CMIC Supports Clinical Trials for Digital Therapeutics Using SUSMED’s Trial Management System

CMIC Co., Ltd. (henceforth “CMIC”)(TOKYO:2309) has launched services using SUSMED, Inc.’s (henceforth “SUSMED”) trial management system covering subject registration, software assignment and distribution for digital therapeutics (DTx).
The system is able to overcome the common challenges of DTx clinical trials, ensuring blinded assignment and preventing unauthorized access. By employing this system, CMIC will offer more efficient operations for DTx trials, such as for the assignment and delivery of software applications (apps) to trial participants, cutting development costs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201115005172/en/

*The system allows for seamless management of both intervention/sham app assignment and app distribution. (Graphic: Business Wire)

In a DTx clinical trial, the software app must be installed on a device, such as a smartphone. Additionally, a placebo app (sham) is often used as a control in comparison to the actual treatment app (intervention), so it is essential that each app is

Read More

Apple honors Veterans Day with Apple Watch activity challenge, extended Apple Music trial

Apple has announced a new Apple Watch activity challenge, plus four months of free Apple Music, for veterans of the US military, National Guard, and Reserve.

As it has before, Apple has added a new activity challenge to Apple Watch, in support of Veterans Day. It’s also offering year-round discounts, plus a four month free trial of Apple Music for veterans who subscribe during November.

“Today and throughout the year, Apple recognizes the immense sacrifices of veterans and their families,” said Apple in a statement. “In honor of Veterans Day, Apple is proud to spotlight veterans stories, legacies, and communities — and to honor and support those who serve.”

Alongside its Apple Music offer, and Apple Watch challenge, Apple says that is working to support veterans organizations. “Apple and its employees are proud to support veterans organizations that are giving back to the community, including non-profits like Team Rubicon,” it

Read More